Sign Up
A 2904 New York Assembly · 2019 Regular Session

Prohibits certain insurance policies from requiring prior authorization for certain medications used in the treatment of substance use disorders; repealer

Summary
Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.
Bill status signed all 5 stages cleared
Introduction
Jan 2019
Committee Review
Apr 2019
Assembly Passage
Apr 2019
Senate Passage
Jun 2019
Signed into Law
Dec 2019
Introduced Jan 28, 2019 Signed Dec 31, 2019
Floor votes · Senate Jun 3, 2019 · Assembly Apr 10, 2019

How they voted

53–0
Passed
Total votes 53
Jun 3, 2019
D Democratic36
36 Yea
100% Yea
R Republican17
17 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
13
Key actions
3
Committee
3
Dec 31, 2019
Signed into law
SIGNED CHAP.748
lower
Jun 3, 2019
Upper · Passed
PASSED SENATE
upper
Apr 10, 2019
Committee
REFERRED TO INSURANCE
upper
Apr 10, 2019
Lower · Passed
PASSED ASSEMBLY
lower
Mar 12, 2019
Committee
REPORTED REFERRED TO CODES
lower
Jan 28, 2019
Committee
REFERRED TO INSURANCE
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.